SEARCH FOR SCI CURE: Swedish company in clinical trials to treat complete spinal cord injuries

FGF1, a growth factor involved in neural regeneration and healing

Here’s a bit of news concerning clinical research that we don’t see a lot of and it concerns those with a complete spinal cord injury. BioArctic, a Swedish company, is currently in Phase I/II trials for a complete spinal cord injury treatment that uses a biodegradable medical device in tandem with a drug to support nerve regeneration across the injured area of the spinal cord.

The device nurtures the growth of central nerves in transplanted grafts of peripheral nerves that protect the new growth from inflammation at the injury. To stimulate nerve regeneration further, the device releases FGF1, a growth factor involved in neural regeneration and healing, as it degrades. The trials are currently in Sweden and Estonia with the goal of expanding them to Finland and Norway.

You can read more about it HERE.